Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: J Urol. 2009 Jun 17;182(2):570–580. doi: 10.1016/j.juro.2009.04.022

Table 6.

Global Response Assessment (GRA) by Treatment Group. Frequencies represent number of patients (n) or n (%) as appropriate. For the GRA portion of the response assessment, responders are defined as those reporting “Markedly Improved” or “Moderately Improved” on the GRA. Patients for whom the GRA value is missing are considered non-responders, and are included in the denominator for the assessment of response rates. Subjects who withdrew are also included in the denominator.

Therapy

GTM MPT Total
Number of Subjects Randomized 24 23 47
Response Rate Based on GRA (p=0.03)
 Responders 5 (21%) 13 (57%) 18 (38%)
 Non-responders 19 (79%) 10 (43%) 29 (62%)
Response Rate for IC/PBS Subgroup (n=26; p= 0.03)
 Responders 1 (7%) 6 (50%) 7 (27%)
 Non-responders 13 (93%) 6 (50%) 19 (73%)
Response Rate for CP/CPPS Subgroup (n=21; p= 0.39)
 Responders 4 (40%) 7 (64%) 11 (52%)
 Non-responders 6 (60%) 4 (36%) 10 (48%)
Global Assessment of Response:
Markedly Improved 3 8 11
Moderately Improved 2 5 7
 Slightly Improved 10 6 16
 No Change 5 2 7
 Slightly Worsened 1 0 1
 Moderately Worsened 1 1 2
 Markedly Worsened 0 0 0
 Missing or Withdrawn 2 1 3